Drug
Vivomixx
Vivomixx: highest development phase Phase 1/2, developed by Perrigo. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Perrigo
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vivomixx NCT03518268 | Phase 1/2 | Breast Cancer |
Latest
No recent events.
Follow Vivomixx on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.